Healthcare at Home
We are the UK’s largest home healthcare provider, transforming healthcare with pharmaceutical and clinical services that put patients and their families first, whilst improving treatment outcomes and reducing treatment costs
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Company Details
Latest Content from PMHub
How pharma companies can use AI to scale personalized engagement without increasing complexity
White Papers and Resources | November 3, 2026 | Inizio
AI is creating a world of opportunities for pharma companies to deliver more personalized HCP and patient engagement. But realizing the full potential of AI takes more than just introducing...
Creating the conditions for product launch success in a time of volatility
White Papers and Resources | November 3, 2026 | Inizio
Volatility is reshaping the conditions for successful product launches. Market dynamics can shift quickly, assumptions can change, and teams are increasingly expected to make confident decisions in response.
Navigating uncertainty in life sciences
White Papers and Resources | November 3, 2026 | Inizio
The life sciences industry is changing fast. Advances in AI, increasingly complex science, shifting market dynamics and evolving patient needs are creating new challenges for organizations developing and commercializing treatments....
Inizio appoints Oisín Ó Gógáin as Chief People Officer
Press Releases | November 3, 2026 | Inizio
Inizio has appointed Oisín Ó Gógáin as Chief People Officer.
Medscape Education Wins “Partner of Hope Award” for Scleroderma Advocacy
Press Releases | October 30, 2026 | Medscape Education
Medscape Education receives National Scleroderma Foundation’s Rocky Mountain Chapter's “Partner of Hope Award” for empowering the patient voice and shortening the diagnostic journey. This recognition honors Medscape Education’s significant commitment...
INmune Bio establishes global commercialization framework for Ebstrocel™ through strategic agreement with Uniphar
Press Releases | October 26, 2026 | Uniphar
Initial focus on named-patient access in selected European and MENA markets, providing a capital-efficient foundation for broader commercialization
Going private: what our year taught me about the patients pharma hasn’t yet spotted
White Papers and Resources | October 26, 2026 | 11 London
A thought piece on the rise of private healthcare, and why brands should help new kinds of patients and HCPs
Redefining Pediatric Epilepsy Care: Why We Must Move Beyond Symptom Suppression
Press Releases | October 21, 2026 | Medscape Education
For families navigating pediatric epilepsy, the condition dictates every moment of their lives. The constant, crippling "anticipatory anxiety" of when the next seizure might hit transforms daily activities like grocery...
What the Most Favored Nation (MFN) policy means for UK Pharma
White Papers and Resources | October 20, 2026 | Amiculum
By Jed Avissar and Manca Povsic
ANTHEM strengthens team with three appointments following Healthy Influence launch
Press Releases | October 19, 2026 | Resonant Group
Healthcare communications consultancy welcomes new talent as it invests in its next phase of growth